| “Deconstruction” of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter R Kolanos, E Solis Jr, F Sakloth, LJ De Felice, RA Glennon ACS chemical neuroscience 4 (12), 1524-1529, 2013 | 86 | 2013 |
| Structural modification of the designer stimulant α-pyrrolidinovalerophenone (α-PVP) influences potency at dopamine transporters R Kolanos, F Sakloth, AD Jain, JS Partilla, MH Baumann, RA Glennon ACS chemical neuroscience 6 (10), 1726-1731, 2015 | 84 | 2015 |
| Quantitative structure–activity relationship analysis of the pharmacology of para‐substituted methcathinone analogues JS Bonano, ML Banks, R Kolanos, F Sakloth, ML Barnier, RA Glennon, ... British journal of pharmacology 172 (10), 2433-2444, 2015 | 69 | 2015 |
| Abuse-related neurochemical effects of para-substituted methcathinone analogs in rats: microdialysis studies of nucleus accumbens dopamine and serotonin JA Suyama, F Sakloth, R Kolanos, RA Glennon, MF Lazenka, SS Negus, ... Journal of Pharmacology and Experimental Therapeutics 356 (1), 182-190, 2016 | 62 | 2016 |
| Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para‐substituted methcathinone analogues F Sakloth, R Kolanos, PD Mosier, JS Bonano, ML Banks, JS Partilla, ... British journal of pharmacology 172 (9), 2210-2218, 2015 | 53 | 2015 |
| Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. F Sakloth, E Leggett, MJ Moerke, EA Townsend, ML Banks, SS Negus Experimental and clinical psychopharmacology 27 (3), 215, 2019 | 48 | 2019 |
| N-Alkylated analogs of 4-methylamphetamine (4-MA) differentially affect monoamine transporters and abuse liability E Solis, JS Partilla, F Sakloth, I Ruchala, KL Schwienteck, LJ De Felice, ... Neuropsychopharmacology 42 (10), 1950-1961, 2017 | 35 | 2017 |
| RGS4 maintains chronic pain symptoms in rodent models K Avrampou, KD Pryce, A Ramakrishnan, F Sakloth, S Gaspari, ... Journal of Neuroscience 39 (42), 8291-8304, 2019 | 33 | 2019 |
| Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway S Gaspari, I Purushothaman, V Cogliani, F Sakloth, RL Neve, D Howland, ... Proceedings of the National Academy of Sciences 115 (9), E2085-E2094, 2018 | 30 | 2018 |
| HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice F Sakloth, L Manouras, K Avrampou, V Mitsi, RA Serafini, KD Pryce, ... Psychopharmacology 237, 2139-2149, 2020 | 29 | 2020 |
| Regulators of G protein signaling in analgesia and addiction F Sakloth, C Polizu, F Bertherat, V Zachariou Molecular Pharmacology 98 (6), 739-750, 2020 | 24 | 2020 |
| A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects KD Pryce, HJ Kang, F Sakloth, Y Liu, S Khan, K Toth, A Kapoor, A Nicolais, ... Neuropharmacology 195, 108673, 2021 | 22 | 2021 |
| Investigation of the optical isomers of methcathinone, and two achiral analogs, at monoamine transporters and in intracranial self-stimulation studies in rats RA Davies, TR Baird, VT Nguyen, B Ruiz, F Sakloth, JM Eltit, SS Negus, ... ACS chemical neuroscience 11 (12), 1762-1769, 2020 | 13 | 2020 |
| Effects of N-Alkyl-4-Methylamphetamine Optical Isomers on Plasma Membrane Monoamine Transporters and Abuse-Related Behavior UM Battisti, R Sitta, A Harris, F Sakloth, D Walther, I Ruchala, SS Negus, ... ACS chemical neuroscience 9 (7), 1829-1839, 2018 | 12 | 2018 |
| Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats. F Sakloth, SS Negus Experimental and clinical psychopharmacology 26 (2), 195, 2018 | 10 | 2018 |
| Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog … F Del Bello, F Sakloth, JS Partilla, MH Baumann, RA Glennon Bioorganic & medicinal chemistry 23 (17), 5574-5579, 2015 | 10 | 2015 |
| Oxycodone withdrawal induces HDAC1/HDAC2-dependent transcriptional maladaptations in the reward pathway in a mouse model of peripheral nerve injury KD Pryce, RA Serafini, A Ramakrishnan, A Nicolais, IM Giosan, C Polizu, ... Nature neuroscience 26 (7), 1229-1244, 2023 | 9 | 2023 |
| GlennonR. A., Cozzi NV, Partilla JS, Baumann MH, Negus SS.: Quantitativestructure-activity relationship analysis of the pharmacologyof para-substituted methcathinone analogues JS Bonano, ML Banks, R Kolanos, F Sakloth, ML Barnier Br. J. Pharmacol 172, 2433-2444, 2015 | 5 | 2015 |
| Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain RA Serafini, M Estill, EA Pekarskaya, F Sakloth, L Shen, JA Javitch, ... Neuropsychopharmacology 48 (11), 1680-1689, 2023 | 4 | 2023 |
| A Regional and Projection-Specific Role of RGSz1 in the Ventrolateral Periaqueductal Grey in the modulation of morphine reward F Sakloth, OB Sanchez-Reyes, A Ruiz, A Nicolais, RA Serafini, KD Pryce, ... Molecular Pharmacology 103 (1), 1-8, 2023 | 3 | 2023 |
